FDA Chief Robert Califf reflects on potential changes as Trump's re-election looms, expressing disappointment and ...

The FDA informed Intercept that it is unable to approve the sNDA in its current form, consistent with the outcome of the Gastrointestinal Drugs Advisory Committee (GIDAC) meeting in September 2024. In ...

The FDA in 2016 granted accelerated approval to the FXR agonist as a second-line treatment for adults with PBC, either in ...

Recently the U.S. Food and Drug Administration (FDA) issued updated safety warnings for all glucagon-like peptide 1 receptor ...

Canalevia®-CA1 is the first and only treatment for chemotherapy-induced diarrhea (CID) in dogs to receive any type of approval from the FDABy prescription only, Canalevia-CA1 is a canine-specific ...

Though HIWU classifies Hemo 15 as a banned substance, Dr. Shell claims he operated under the impression that it was a ...

Compass Pathways is advancing pivotal trials to test psilocybin's impact on treatment-resistant depression. See why I rate ...

After a rough offseason of rebuilding its roster following a mass exodus through the transfer portal, Virginia Tech is ready ...

Quarterback Matthew Sluka, who left UNLV three games into the season over a name, image and likeness dispute, has entered the ...

Scemblix (asciminib) is a new first-line option for adults with newly diagnosed Philadelphia chromosome-positive chronic ...

Northwestern enters 2024-25 coming off consecutive NCAA Tournament appearances for the first time in school history and ...

The EcoWaste Coalition has called attention to the proliferation of unauthorized cosmetics in online shopping platforms ...